research A Case of Atopic Dermatitis with Alopecia Universalis in a Patient Treated with Abrocitinib
Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.
Search
forLearn
0 / 0 results — no results
Research
5 / 71 results
research Current Options and Treatment Strategies for Alopecia Areata in Comorbidity with Atopic Diseases
Dupilumab and oral JAK inhibitors are effective for treating alopecia areata with atopic diseases.
research Successful Treatment of Alopecia Universalis With Abrocitinib: A Case Report
Abrocitinib may effectively treat stubborn alopecia universalis.
research Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.
research Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
JAK inhibitors show promise for treating various skin diseases.
Community Join
0 / 0 results — no results